Skip to main content
Premium Trial:

Request an Annual Quote

The Pushing Aside of the CDC

Two former political appointees at the US Centers for Disease Control and Prevention tell the New York Times about how the White House pushed the agency aside during the COVID-19 pandemic this past year.

"Everyone wants to describe the day that the light switch flipped and the CDC was sidelined. It didn't happen that way," Kyle McGowan, a former chief of staff at the CDC, says at the Times. "It was more of like a hand grasping something, and it slowly closes, closes, closes, closes until you realize that, middle of the summer, it has a complete grasp on everything at the CDC."

In September, the Times reported on emails that indicated that a Department of Health and Human Services spokesperson and his science advisor sought to silence CDC officials, while Politico reported that political appointees at CDC sought to review and alter items in the CDC's Morbidity and Mortality Weekly Reports.

McGowan and Amanda Campbell, a former deputy chief of staff at CDC, tell the Times that they tried to protect against political interference at the agency, but McGowan says that whenever the science contradicted the message the White House wanted to express, the political messaging won out.

"Damage has been done to the CDC that will take years to undo," McGowan adds at the Times. "And that's terrible to hear, because it happened under my time there."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.